Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991–2003
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 13 (4) , 621-638
- https://doi.org/10.1016/j.soc.2004.06.004
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Adjuvant therapy for pancreatic cancer: back to the futureInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Radiation therapy and 5-fluorouracil in pancreatic cancerSeminars in Radiation Oncology, 1997
- Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990sAnnals of Surgery, 1997
- Adjuvant Therapy with Chemotherapy and Radiation Therapy in the Management of Carcinoma of the Pancreatic HeadSurgical Clinics of North America, 1995
- Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 PatientsAnnals of Surgery, 1995
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- One Hundred and Forty-Five Consecutive Pancreaticoduodenectomies Without MortalityAnnals of Surgery, 1993
- Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancerCancer, 1987
- Pancreatic CancerArchives of Surgery, 1985